Associate Director, DCT Operations Manager
Karen van Benschoten is a member of Bayer’s DCT Strategy and Implementation Team. This specialized team evolved from an innovation initiative in 2019, to further pursue a better means of patient centricity and exploration of new digital technologies. Since then, Bayer has implemented DCT in multiple global clinical trials, inclusive of hybrid and fully remote designs.
With 25+ years of industry experience, Karen’s operational and management expertise spans site, CRO and sponsor organizations. In addition to DCT, she has been involved in several taskforce initiatives related to Site Relations, Risk Based Monitoring, Change Management, Resourcing and Peer Mentorship.